0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Next Generation Cancer Diagnostics Market Insights and Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-24F2154
Home | Market Reports | Health | Health Conditions | Cancer
Global Next Generation Cancer Diagnostics Market Insights and Forecast to 2028

Global Next Generation Cancer Diagnostics Market Insights and Forecast to 2028

Code: QYRE-Auto-24F2154
Report
February 2022
113 Pages
QYResearch
Region: Global, North America, Europe, Japan, Central & South America,
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Next Generation Cancer Diagnostics Market

The global Next Generation Cancer Diagnostics market size is projected to reach US$ 20950 million by 2028, from US$ 6198.2 million in 2021, at a CAGR of 18.5% during 2022-2028.

Fully considering the economic change by this health crisis, Next Generation Sequencing accounting for % of the Next Generation Cancer Diagnostics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Next Generation Cancer Diagnostics market size is valued at US$ million in 2021, while the North America and Europe Next Generation Cancer Diagnostics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Next Generation Cancer Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Next Generation Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Next Generation Cancer Diagnostics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Next Generation Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Next Generation Cancer Diagnostics market.
Global Next Generation Cancer Diagnostics Scope and Market Size
Next Generation Cancer Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Next Generation Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others

Segment by Application

Hospitals
Clinics
Others

BY COMPANY

Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Next Generation Sequencing
1.2.3 qPCR & Multiplexing
1.2.4 DNA Microarrays
1.2.5 Others
1.3 Market by Application
1.3.1 Global Next Generation Cancer Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Cancer Diagnostics Market Perspective (2017-2028)
2.2 Next Generation Cancer Diagnostics Growth Trends by Region
2.2.1 Next Generation Cancer Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Next Generation Cancer Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Next Generation Cancer Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Next Generation Cancer Diagnostics Market Dynamics
2.3.1 Next Generation Cancer Diagnostics Industry Trends
2.3.2 Next Generation Cancer Diagnostics Market Drivers
2.3.3 Next Generation Cancer Diagnostics Market Challenges
2.3.4 Next Generation Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Cancer Diagnostics Players by Revenue
3.1.1 Global Top Next Generation Cancer Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Next Generation Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Cancer Diagnostics Revenue
3.4 Global Next Generation Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Next Generation Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Cancer Diagnostics Revenue in 2021
3.5 Next Generation Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Next Generation Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Next Generation Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Cancer Diagnostics Breakdown Data by Type
4.1 Global Next Generation Cancer Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2023-2028)
5 Next Generation Cancer Diagnostics Breakdown Data by Application
5.1 Global Next Generation Cancer Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Next Generation Cancer Diagnostics Market Size (2017-2028)
6.2 North America Next Generation Cancer Diagnostics Market Size by Type
6.2.1 North America Next Generation Cancer Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Next Generation Cancer Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Next Generation Cancer Diagnostics Market Share by Type (2017-2028)
6.3 North America Next Generation Cancer Diagnostics Market Size by Application
6.3.1 North America Next Generation Cancer Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Next Generation Cancer Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Next Generation Cancer Diagnostics Market Share by Application (2017-2028)
6.4 North America Next Generation Cancer Diagnostics Market Size by Country
6.4.1 North America Next Generation Cancer Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Next Generation Cancer Diagnostics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Next Generation Cancer Diagnostics Market Size (2017-2028)
7.2 Europe Next Generation Cancer Diagnostics Market Size by Type
7.2.1 Europe Next Generation Cancer Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Next Generation Cancer Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Next Generation Cancer Diagnostics Market Share by Type (2017-2028)
7.3 Europe Next Generation Cancer Diagnostics Market Size by Application
7.3.1 Europe Next Generation Cancer Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Next Generation Cancer Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Next Generation Cancer Diagnostics Market Share by Application (2017-2028)
7.4 Europe Next Generation Cancer Diagnostics Market Size by Country
7.4.1 Europe Next Generation Cancer Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Next Generation Cancer Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Next Generation Cancer Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Next Generation Cancer Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Next Generation Cancer Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Next Generation Cancer Diagnostics Market Size (2017-2028)
9.2 Latin America Next Generation Cancer Diagnostics Market Size by Type
9.2.1 Latin America Next Generation Cancer Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Next Generation Cancer Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Next Generation Cancer Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Next Generation Cancer Diagnostics Market Size by Application
9.3.1 Latin America Next Generation Cancer Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Next Generation Cancer Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Next Generation Cancer Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Next Generation Cancer Diagnostics Market Size by Country
9.4.1 Latin America Next Generation Cancer Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Next Generation Cancer Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Next Generation Cancer Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Next Generation Cancer Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Cepheid
11.1.1 Cepheid Company Details
11.1.2 Cepheid Business Overview
11.1.3 Cepheid Next Generation Cancer Diagnostics Introduction
11.1.4 Cepheid Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.1.5 Cepheid Recent Developments
11.2 Koninklijke Philips N.V
11.2.1 Koninklijke Philips N.V Company Details
11.2.2 Koninklijke Philips N.V Business Overview
11.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Introduction
11.2.4 Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.2.5 Koninklijke Philips N.V Recent Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.3.5 F. Hoffmann-La Roche Ltd Recent Developments
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Next Generation Cancer Diagnostics Introduction
11.4.4 Qiagen Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.4.5 Qiagen Recent Developments
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Next Generation Cancer Diagnostics Introduction
11.5.4 Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.5.5 Novartis AG Recent Developments
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Next Generation Cancer Diagnostics Introduction
11.6.4 Abbott Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.6.5 Abbott Recent Developments
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Introduction
11.7.4 Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.7.5 Thermo Fisher Scientific Recent Developments
11.8 Opko Health
11.8.1 Opko Health Company Details
11.8.2 Opko Health Business Overview
11.8.3 Opko Health Next Generation Cancer Diagnostics Introduction
11.8.4 Opko Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.8.5 Opko Health Recent Developments
11.9 Myriad Genetics
11.9.1 Myriad Genetics Company Details
11.9.2 Myriad Genetics Business Overview
11.9.3 Myriad Genetics Next Generation Cancer Diagnostics Introduction
11.9.4 Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.9.5 Myriad Genetics Recent Developments
11.10 Agilent Technologies
11.10.1 Agilent Technologies Company Details
11.10.2 Agilent Technologies Business Overview
11.10.3 Agilent Technologies Next Generation Cancer Diagnostics Introduction
11.10.4 Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.10.5 Agilent Technologies Recent Developments
11.11 GE Healthcare
11.11.1 GE Healthcare Company Details
11.11.2 GE Healthcare Business Overview
11.11.3 GE Healthcare Next Generation Cancer Diagnostics Introduction
11.11.4 GE Healthcare Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.11.5 GE Healthcare Recent Developments
11.12 PerkinElmer
11.12.1 PerkinElmer Company Details
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Next Generation Cancer Diagnostics Introduction
11.12.4 PerkinElmer Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.12.5 PerkinElmer Recent Developments
11.13 Genomic Health
11.13.1 Genomic Health Company Details
11.13.2 Genomic Health Business Overview
11.13.3 Genomic Health Next Generation Cancer Diagnostics Introduction
11.13.4 Genomic Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.13.5 Genomic Health Recent Developments
11.14 Illumina
11.14.1 Illumina Company Details
11.14.2 Illumina Business Overview
11.14.3 Illumina Next Generation Cancer Diagnostics Introduction
11.14.4 Illumina Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.14.5 Illumina Recent Developments
11.15 Hologic
11.15.1 Hologic Company Details
11.15.2 Hologic Business Overview
11.15.3 Hologic Next Generation Cancer Diagnostics Introduction
11.15.4 Hologic Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.15.5 Hologic Recent Developments
11.16 Almac Group
11.16.1 Almac Group Company Details
11.16.2 Almac Group Business Overview
11.16.3 Almac Group Next Generation Cancer Diagnostics Introduction
11.16.4 Almac Group Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.16.5 Almac Group Recent Developments
11.17 Janssen Global Services
11.17.1 Janssen Global Services Company Details
11.17.2 Janssen Global Services Business Overview
11.17.3 Janssen Global Services Next Generation Cancer Diagnostics Introduction
11.17.4 Janssen Global Services Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.17.5 Janssen Global Services Recent Developments
11.18 Sysmex Corporation
11.18.1 Sysmex Corporation Company Details
11.18.2 Sysmex Corporation Business Overview
11.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Introduction
11.18.4 Sysmex Corporation Revenue in Next Generation Cancer Diagnostics Business (2017-2022)
11.18.5 Sysmex Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Next Generation Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Next Generation Sequencing
    Table 3. Key Players of qPCR & Multiplexing
    Table 4. Key Players of DNA Microarrays
    Table 5. Key Players of Others
    Table 6. Global Next Generation Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Next Generation Cancer Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Next Generation Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Next Generation Cancer Diagnostics Market Share by Region (2017-2022)
    Table 10. Global Next Generation Cancer Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Next Generation Cancer Diagnostics Market Share by Region (2023-2028)
    Table 12. Next Generation Cancer Diagnostics Market Trends
    Table 13. Next Generation Cancer Diagnostics Market Drivers
    Table 14. Next Generation Cancer Diagnostics Market Challenges
    Table 15. Next Generation Cancer Diagnostics Market Restraints
    Table 16. Global Next Generation Cancer Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Next Generation Cancer Diagnostics Revenue Share by Players (2017-2022)
    Table 18. Global Top Next Generation Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostics as of 2021)
    Table 19. Ranking of Global Top Next Generation Cancer Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Next Generation Cancer Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Next Generation Cancer Diagnostics Product Solution and Service
    Table 23. Date of Enter into Next Generation Cancer Diagnostics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2017-2022)
    Table 27. Global Next Generation Cancer Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Next Generation Cancer Diagnostics Revenue Market Share by Type (2023-2028)
    Table 29. Global Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Next Generation Cancer Diagnostics Revenue Share by Application (2017-2022)
    Table 31. Global Next Generation Cancer Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Next Generation Cancer Diagnostics Revenue Share by Application (2023-2028)
    Table 33. North America Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Next Generation Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Next Generation Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Next Generation Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Next Generation Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Next Generation Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Next Generation Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Next Generation Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Next Generation Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Next Generation Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Next Generation Cancer Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Next Generation Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Next Generation Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Next Generation Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Next Generation Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Cepheid Company Details
    Table 64. Cepheid Business Overview
    Table 65. Cepheid Next Generation Cancer Diagnostics Product
    Table 66. Cepheid Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 67. Cepheid Recent Developments
    Table 68. Koninklijke Philips N.V Company Details
    Table 69. Koninklijke Philips N.V Business Overview
    Table 70. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product
    Table 71. Koninklijke Philips N.V Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 72. Koninklijke Philips N.V Recent Developments
    Table 73. F. Hoffmann-La Roche Ltd Company Details
    Table 74. F. Hoffmann-La Roche Ltd Business Overview
    Table 75. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product
    Table 76. F. Hoffmann-La Roche Ltd Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 77. F. Hoffmann-La Roche Ltd Recent Developments
    Table 78. Qiagen Company Details
    Table 79. Qiagen Business Overview
    Table 80. Qiagen Next Generation Cancer Diagnostics Product
    Table 81. Qiagen Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 82. Qiagen Recent Developments
    Table 83. Novartis AG Company Details
    Table 84. Novartis AG Business Overview
    Table 85. Novartis AG Next Generation Cancer Diagnostics Product
    Table 86. Novartis AG Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 87. Novartis AG Recent Developments
    Table 88. Abbott Company Details
    Table 89. Abbott Business Overview
    Table 90. Abbott Next Generation Cancer Diagnostics Product
    Table 91. Abbott Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 92. Abbott Recent Developments
    Table 93. Thermo Fisher Scientific Company Details
    Table 94. Thermo Fisher Scientific Business Overview
    Table 95. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product
    Table 96. Thermo Fisher Scientific Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 97. Thermo Fisher Scientific Recent Developments
    Table 98. Opko Health Company Details
    Table 99. Opko Health Business Overview
    Table 100. Opko Health Next Generation Cancer Diagnostics Product
    Table 101. Opko Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 102. Opko Health Recent Developments
    Table 103. Myriad Genetics Company Details
    Table 104. Myriad Genetics Business Overview
    Table 105. Myriad Genetics Next Generation Cancer Diagnostics Product
    Table 106. Myriad Genetics Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 107. Myriad Genetics Recent Developments
    Table 108. Agilent Technologies Company Details
    Table 109. Agilent Technologies Business Overview
    Table 110. Agilent Technologies Next Generation Cancer Diagnostics Product
    Table 111. Agilent Technologies Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 112. Agilent Technologies Recent Developments
    Table 113. GE Healthcare Company Details
    Table 114. GE Healthcare Business Overview
    Table 115. GE Healthcare Next Generation Cancer Diagnostics Product
    Table 116. GE Healthcare Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 117. GE Healthcare Recent Developments
    Table 118. PerkinElmer Company Details
    Table 119. PerkinElmer Business Overview
    Table 120. PerkinElmer Next Generation Cancer Diagnostics Product
    Table 121. PerkinElmer Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 122. PerkinElmer Recent Developments
    Table 123. Genomic Health Company Details
    Table 124. Genomic Health Business Overview
    Table 125. Genomic Health Next Generation Cancer Diagnostics Product
    Table 126. Genomic Health Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 127. Genomic Health Recent Developments
    Table 128. Illumina Company Details
    Table 129. Illumina Business Overview
    Table 130. Illumina Next Generation Cancer Diagnostics Product
    Table 131. Illumina Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 132. Illumina Recent Developments
    Table 133. Hologic Company Details
    Table 134. Hologic Business Overview
    Table 135. Hologic Next Generation Cancer Diagnostics Product
    Table 136. Hologic Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 137. Hologic Recent Developments
    Table 138. Almac Group Company Details
    Table 139. Almac Group Business Overview
    Table 140. Almac Group Next Generation Cancer Diagnostics Product
    Table 141. Almac Group Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 142. Almac Group Recent Developments
    Table 143. Janssen Global Services Company Details
    Table 144. Janssen Global Services Business Overview
    Table 145. Janssen Global Services Next Generation Cancer Diagnostics Product
    Table 146. Janssen Global Services Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 147. Janssen Global Services Recent Developments
    Table 148. Sysmex Corporation Company Details
    Table 149. Sysmex Corporation Business Overview
    Table 150. Sysmex Corporation Next Generation Cancer Diagnostics Product
    Table 151. Sysmex Corporation Revenue in Next Generation Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 152. Sysmex Corporation Recent Developments
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Next Generation Cancer Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Next Generation Sequencing Features
    Figure 3. qPCR & Multiplexing Features
    Figure 4. DNA Microarrays Features
    Figure 5. Others Features
    Figure 6. Global Next Generation Cancer Diagnostics Market Share by Application: 2021 VS 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Next Generation Cancer Diagnostics Report Years Considered
    Figure 11. Global Next Generation Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Next Generation Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Next Generation Cancer Diagnostics Market Share by Region: 2021 VS 2028
    Figure 14. Global Next Generation Cancer Diagnostics Market Share by Players in 2021
    Figure 15. Global Top Next Generation Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Next Generation Cancer Diagnostics Revenue in 2021
    Figure 17. North America Next Generation Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 19. North America Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 20. North America Next Generation Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 21. United States Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Next Generation Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Next Generation Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 27. Germany Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Next Generation Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Next Generation Cancer Diagnostics Market Size Share by Region (2017-2028)
    Figure 37. China Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Next Generation Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Next Generation Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 47. Mexico Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Next Generation Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Next Generation Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 53. Turkey Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Next Generation Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Cepheid Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 57. Koninklijke Philips N.V Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 58. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 59. Qiagen Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 60. Novartis AG Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 61. Abbott Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 63. Opko Health Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 64. Myriad Genetics Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 65. Agilent Technologies Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 66. GE Healthcare Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 67. PerkinElmer Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 68. Genomic Health Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 69. Illumina Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 70. Hologic Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 71. Almac Group Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 72. Janssen Global Services Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 73. Sysmex Corporation Revenue Growth Rate in Next Generation Cancer Diagnostics Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

Global and United States Blood Cancer Therapeutics Market Report Forecast 2022 2028
Global and United States Blood Cancer Therapeutics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-24U5687
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Ovarian Cancer Diagnostics Technologies Market Report Forecast 2022 2028
Global and United States Ovarian Cancer Diagnostics Technologies Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-23K5690
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Cancer Biotherapy Market Report Forecast 2022 2028
Global and United States Cancer Biotherapy Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-18N5929
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Emerging Cancer Diagnostics Market Report Forecast 2022 2028
Global and United States Emerging Cancer Diagnostics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-12C6010
Tue Jun 07 00:00:00 UTC 2022

Add to Cart